- Bevacizumab/trifluridine/tipiracil/pegfilgrastim
, 2022, Reactions Weekly CrossRef - Biosimilars in Colorectal Cancer
Meghana Patel et al, 2024, Biosimilars for Cancer Treatment CrossRef - A Systematic Review and Meta-Analysis of Trifluridine/Tipiracil plus Bevacizumab for the Treatment of Metastatic Colorectal Cancer: Evidence from Real-World Series
Ioannis A. Voutsadakis, 2023, Current Oncology CrossRef